NL-OMON34092已完成4 期
PE-Prove Study PROMUS* Element* Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study A prospective, open label, multi-center observational study - PE-Prove study
Boston Scientific International S.A.0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients who are candidates for Coronary artery stenting, signed the Informed Consent Form and are eligible to receive a PROMUS* Element* stent will be evaluated for enrollment in this study.
排除标准
- •No study-specific exclusion criteria apart from any contra-indications
- •Page 20-21 protocol
研究者
相似试验
招募中
不适用
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis)Complex coronary artery diseaseJPRN-UMIN000021122The PCI Guideline Research Society50
尚未招募
不适用
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion SubsetsJPRN-UMIN000008651The PCI Guideline Research Society800
Unknown
不适用
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion SubsetsCoronary Artery DiseaseNCT01670318The PCI Guideline Research Society800
已完成
3 期
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Coronary Artery DiseaseNCT01500434Boston Scientific Corporation102
已完成
不适用
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCoronary Artery DiseaseNCT01498692Boston Scientific Corporation94